The University of Texas MD Anderson Cancer Center applauds the Texas Legislature today for passing Senate Bill 21, which raises the minimum legal sale age for all tobacco products from 18 to 21. The policy, which will go into effect on September 1, 2019, is an important step toward protecting the health of future generations and reducing the burden of tobacco use in Texas.
The legislation was authored by Sen. Joan Huffman, with...
The University of Texas MD Anderson Cancer Center today named David Jaffray, Ph.D., as its first-ever chief technology and digital officer...
Despite a Saturday morning storm that wreaked havoc on plans for this year’s Polo on the Prairie, May 18 at the Musselman Brothers’ Lazy 3...
An immunotherapy combination with a higher dose of ipilimumab produced a 38 percent overall response rate for patients with metastatic bladder cancer in a clinical trial led by investigators at The University of Texas MD Anderson Cancer Center that examined single-agent nivolumab and two combinations of the immune checkpoint inhibitors.
Progression-free survival and overall survival also were higher for patients given the combination...
The University of Texas MD Anderson Cancer Center applauds the 86th Texas Legislature today for voting to approve a constitutional amendment...
The University of Texas MD Anderson Cancer Center has received full accreditation by the American Association for Physician Leadership...
A study at The University of Texas MD Anderson Cancer Center
demonstrated how a small molecule drug discovered...
The University of Texas MD Anderson Cancer Center has named eight researchers to the fourth annual class of Andrew Sabin Family Fellows. Each...
A study at The University of Texas MD Anderson Cancer Center identified a new therapeutic target in cancer cells and explains how new anti-cancer...
An open-label, multi-cohort Phase II trial, led by investigators at The University of Texas MD Anderson Cancer Center, reports that treatment...